Patents by Inventor Marc PEETERS

Marc PEETERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT
    Publication number: 20240010740
    Abstract: The present invention relates to the field of combination immunotherapy, more in particular to a combination comprising ILL-15 and a CD40 agonist for use in the treatment of cancer, such as and not limited to, melanoma skin cancer (e.g.: superficial spreading melanoma, nodular melanoma, acral-lentiginous melanoma, lentigo maligna melanoma, amelanotic and desmoplastic melanomas, ocular melanoma, and metastatic melanoma).
    Type: Application
    Filed: December 3, 2021
    Publication date: January 11, 2024
    Inventors: Jonas VAN AUDENAERDE, Evelien SMITS, Marc PEETERS
  • COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT
    Publication number: 20240009275
    Abstract: The present invention relates to the field of combination immunotherapy, more in particular to a combination comprising IL-15 and a CD40 agonist for use in the treatment of cancer, such as and not limited to mesothelioma (e.g. pleural, peritoneal, pericardial or testicular mesothelioma).
    Type: Application
    Filed: December 3, 2021
    Publication date: January 11, 2024
    Inventors: Jonas VAN AUDENAERDE, Evelien SMITS, Marc PEETERS
  • METHYLATION STATUS OF GASDERMIN E GENE AS CANCER BIOMARKER
    Publication number: 20230183807
    Abstract: The present invention applies to the area of cancer diagnostics. In particular, the present invention is directed to a method for the ex vivo differential diagnosis between several cancer types in a subject based on the methylation status of the Gasdermin E (GSDME) gene. In a further aspect, the present invention relates to a method for the ex vivo differential diagnosis between several cancer types based on the methylation status of at least 2 CpG sites in the GSDME gene.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 15, 2023
    Inventors: Joe Ibrahim, Ken Op de Beeck, Arvid Suls, Guido Van Camp, Marc Peeters
  • COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT
    Publication number: 20220411524
    Abstract: The present invention relates to the field of combination immunotherapy, more in particular to a combination comprising IL-15 and a CD40 agonist for use in the treatment of cancer, such as and not limited to, pancreatic cancer (e.g. pancreatic ductal adenocarcinoma and pancreatic neuro-endocrine tumours).
    Type: Application
    Filed: December 4, 2020
    Publication date: December 29, 2022
    Applicants: UNIVERSITEIT ANTWERPEN, UNIVERSITAIR ZIEKENHUIS ANTWERPEN
    Inventors: Evelien SMITS, Jonas VANAUDENAERDE, Marc PEETERS